INSMED INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
INSMED INC (INSM) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$3.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$3.38M, a 228.21% decline year-over-year.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$1.46M, a 205.05% decline year-over-year.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$537.00K.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $266.00K, a 92.12% decline year-over-year.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $3.75M.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$1.54M.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$1.50M.
- INSMED INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$212.00K, a 127.35% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.38M 10-Q · filed 2026-08-06 | -$4.83M 10-Q · filed 2026-08-06 | -$5.37M derived: sum of 3 quarters · filed 2026-08-06 | -$5.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.46M 10-Q · filed 2026-05-07 | -$1.99M derived: sum of 2 quarters · filed 2026-05-07 | -$1.73M derived: sum of 3 quarters · filed 2026-05-07 | $906.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$271.00K derived: sum of 2 quarters · filed 2026-02-19 | $2.36M derived: sum of 3 quarters · filed 2026-08-06 | $3.75M 10-K · filed 2026-02-19 |
| 2025-09-30 | $266.00K 10-Q · filed 2025-10-30 | $2.90M derived: sum of 2 quarters · filed 2026-08-06 | $4.29M 10-Q · filed 2025-10-30 | $1.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.63M 10-Q · filed 2026-08-06 | $4.02M 10-Q · filed 2026-08-06 | $1.19M derived: sum of 3 quarters · filed 2026-08-06 | $4.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.39M 10-Q · filed 2026-05-07 | -$1.45M derived: sum of 2 quarters · filed 2026-05-07 | $1.93M derived: sum of 3 quarters · filed 2026-05-07 | $734.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $541.00K derived: sum of 2 quarters · filed 2026-02-19 | -$653.00K derived: sum of 3 quarters · filed 2026-02-19 | -$1.54M 10-K · filed 2026-02-19 |
| 2024-09-30 | $3.38M 10-Q · filed 2025-10-30 | $2.18M derived: sum of 2 quarters · filed 2025-10-30 | $1.29M 10-Q · filed 2025-10-30 | $2.63M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$1.19M 10-Q · filed 2025-08-07 | -$2.08M 10-Q · filed 2025-08-07 | -$752.00K derived: sum of 3 quarters · filed 2026-02-19 | -$1.58M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$891.00K 10-Q · filed 2025-05-08 | $442.00K derived: sum of 2 quarters · filed 2026-02-19 | -$385.00K derived: sum of 3 quarters · filed 2026-02-19 | -$2.72M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $506.00K derived: sum of 2 quarters · filed 2026-02-19 | -$1.83M derived: sum of 3 quarters · filed 2026-02-19 | -$1.50M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$827.00K 10-Q · filed 2024-10-31 | -$3.16M derived: sum of 2 quarters · filed 2024-10-31 | -$2.83M 10-Q · filed 2024-10-31 | -$692.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$2.33M 10-Q · filed 2024-08-08 | -$2.01M 10-Q · filed 2024-08-08 | $135.00K derived: sum of 3 quarters · filed 2025-02-20 | -$322.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $327.00K 10-Q · filed 2024-05-09 | $2.47M derived: sum of 2 quarters · filed 2025-02-20 | $2.01M derived: sum of 3 quarters · filed 2025-02-20 | $1.31M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.69M derived: sum of 2 quarters · filed 2025-02-20 | $986.00K derived: sum of 3 quarters · filed 2025-02-20 | -$212.00K 10-K · filed 2025-02-20 |
| 2022-09-30 | -$457.00K 10-Q · filed 2023-10-26 | -$1.16M derived: sum of 2 quarters · filed 2023-10-26 | -$2.35M 10-Q · filed 2023-10-26 | -$1.49M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$699.00K 10-Q · filed 2023-08-03 | -$1.90M 10-Q · filed 2023-08-03 | -$1.03M derived: sum of 3 quarters · filed 2024-02-22 | -$1.35M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$1.20M 10-Q · filed 2023-05-04 | -$330.00K derived: sum of 2 quarters · filed 2024-02-22 | -$654.00K derived: sum of 3 quarters · filed 2024-02-22 | -$320.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $868.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $544.00K derived: sum of 2 quarters · filed 2024-02-22 | $878.00K derived: sum of 3 quarters · filed 2024-02-22 | $775.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | -$324.00K 10-Q · filed 2022-10-27 | $10.00K derived: sum of 2 quarters · filed 2022-10-27 | -$93.00K 10-Q · filed 2022-10-27 | -$14.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $334.00K 10-Q · filed 2022-08-04 | $231.00K 10-Q · filed 2022-08-04 | $310.00K derived: sum of 3 quarters · filed 2023-02-23 | $522.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$103.00K 10-Q · filed 2022-05-05 | -$24.00K derived: sum of 2 quarters · filed 2023-02-23 | $188.00K derived: sum of 3 quarters · filed 2023-02-23 | $137.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $291.00K derived: sum of 2 quarters · filed 2023-02-23 | $240.00K derived: sum of 3 quarters · filed 2023-02-23 | $203.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $212.00K 10-Q · filed 2021-10-28 | $161.00K derived: sum of 2 quarters · filed 2021-10-28 | $124.00K 10-Q · filed 2021-10-28 | $122.00K derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | -$51.00K 10-Q · filed 2021-08-05 | -$88.00K 10-Q · filed 2021-08-05 | -$90.00K derived: sum of 3 quarters · filed 2022-02-17 | -$91.00K derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | -$37.00K 10-Q · filed 2021-05-06 | -$39.00K derived: sum of 2 quarters · filed 2022-02-17 | -$40.00K derived: sum of 3 quarters · filed 2022-02-17 | -$77.00K derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$3.00K derived: sum of 2 quarters · filed 2022-02-17 | -$40.00K derived: sum of 3 quarters · filed 2022-02-17 | -$1.00K 10-K · filed 2022-02-17 |
| 2019-09-30 | -$1.00K 10-Q · filed 2020-10-29 | -$38.00K derived: sum of 2 quarters · filed 2020-10-29 | $1.00K 10-Q · filed 2020-10-29 | -$28.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$37.00K 10-Q · filed 2020-08-06 | $2.00K 10-Q · filed 2020-08-06 | -$27.00K derived: sum of 3 quarters · filed 2021-02-25 | -$25.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $39.00K 10-Q · filed 2020-04-30 | $10.00K derived: sum of 2 quarters · filed 2021-02-25 | $12.00K derived: sum of 3 quarters · filed 2021-02-25 | -$9.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$27.00K derived: sum of 2 quarters · filed 2021-02-25 | -$48.00K derived: sum of 3 quarters · filed 2021-02-25 | -$6.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.00K 10-Q · filed 2019-10-30 | -$19.00K derived: sum of 2 quarters · filed 2019-10-30 | $23.00K 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$21.00K 10-Q · filed 2019-08-01 | $21.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $42.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $62.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | -$65.00K 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |